Ben Johnson 🦠📝

Magazine Editor at @NatureMedicine and occasional writer on science, technology and health. Ex virologist 🦠 Charity trustee in Southwark, London 🏳️‍🌈

[Ben Johnson 🦠📝 @drbenjohnson]

CRISPR-containing bacteriophages are being developed by biotechs as an alternative to antibiotics.
These viruses can kill harmful bacteria without damaging the healthy microbiome.
Read more in my News analysis for @NatureBiotech

https://t.co/CzGXpQS3m1

[TRUSTproject @TRUST_Project]

Thank you @NatureMedicine for emphasizing the strong equity elements of the revised @medwma Declaration of Helsinki and citing the TRUST and the San Code! https://t.co/tyU35m1f5v

[TRUSTproject @TRUST_Project]

Brilliant news, another high-profile adopter for the TRUST Code taking a stance against inequitable research, the Pasteur Network, alliance of 32 institutes in 25 countries across 5 continents, https://t.co/tlzL3oSByS

[The Lancet @TheLancet]

GLP-1 receptor agonists, which are effective for weight loss, can cause substantial muscle loss.

A Comment in @TheLancetEndo discusses the effects of GLP-1 receptor agonists on skeletal muscle mass: https://t.co/PySJT9uC7f

[Nature Medicine @NatureMedicine]

Health AI needs meaningful human involvement: lessons from war.

Correspondence from James M. Hillis & Kenneth Payne @KingsCollegeLon @harvardmed

https://t.co/eH7498ejZt

[Nature Medicine @NatureMedicine]

The use and misuse of ‘biological aging’ in health research.

World View by M. Arfan Ikram @erasmusuni

https://t.co/0LUvA2h1t1

[Otavio Berwanger @OtavioBerwanger]

Our paper just published in Nature Medicine. @NatureMedicine

How to Make Cardiology Trials More Inclusive?

https://t.co/cMX0u03JK5

Great collaborative effort led by @hvanspall and @FaiezZANNAD

@CMichaelGibson @NMHheartdoc @kamleshkhunti @TomLuscher and many others

[Africa CDC @AfricaCDC]

Rwanda’s Health Minister Dr. @nsanzimanasabin points to progress in controlling the #Marburg outbreak, assuring that measures are in place to safeguard travellers and conference attendees.

[Nature Medicine @NatureMedicine]

PROTAC protein degraders to 'drug the undruggable' enter phase 3 trials.

Read the latest Clinical Pipeline, by @edbites

https://t.co/p69iy6onml

[Africa CDC @AfricaCDC]

Join us for this week’s press briefing as @AfricaCDC Director General, Dr. @JeanKaseya2, and Rwanda's Minister of Health, Dr. @nsanzimanasabin, provide critical updates on the Mpox outbreak across @_AfricanUnion Member States. Dr. Nsanzimana will also highlight the Marburg outbreak in Rwanda and the urgent actions being taken to address it.

📅 Date: 03 October 2024
🕞 Time:
16:00 – 17:00 | East Africa Time (GMT+3)
15:00 – 16:00 | Southern Africa Time (GMT+2)
14:00 – 15:00 | Central Africa Countries (GMT+1)
🔗 Join virtually via Zoom: https://t.co/DgO1Vd3Mht

[Nature Medicine @NatureMedicine]

⭐Research highlight: Daily injection with the weight-loss drug #liraglutide was more effective than placebo (both combined with lifestyle interventions) at reducing weight in children aged 6–12 years with #obesity. @NEJM
https://t.co/TWRltPbPM2

[Nature Medicine @NatureMedicine]

The role of @US_FDA advisory committees.

Comment from Emily C. Helms Williams, Namandjé N. Bumpus and @DrCaliff_FDA

https://t.co/SAI1YzsWx5

[Africa CDC @AfricaCDC]

#Mpox cases are rising across Africa, highlighting gaps in surveillance and testing. “Some countries report suspected cases, but without testing, we can’t confirm them or classify outbreaks,” said @AfricaCDC Director General Dr @JeanKaseya2. Contract tracing is another challenge: “We aim to trace 90% of contacts but have only reached around 4%, reflecting the performance of our surveillance systems."

[Nature Medicine @NatureMedicine]

A novel application of #ASO technology adds to the growing number of personalized therapies for rare diseases; but pathways to implementation & access are urgently needed
News & Views from Annemieke Aartsma-Rus & colleagues
@oligogirl @LUMC_Leiden @uni_tue
https://t.co/L18edxFVWD

[Nature Computational Science @NatComputSci]

📢Our September issue is now live, and includes a Focus on the state of DEI in computational science, highlighting experts' insights on ongoing challenges and strategies for creating a more diverse, equitable, and inclusive field for all.

➡️https://t.co/Q2wC0Ynm5z

🧵(1/11)

[Maria Van Kerkhove @mvankerkhove]

There is a pervasive myth that the DRC 🇨🇩 and other countries in Africa affected by the current #mpox outbreak lack capacity for the many elements that are needed for effective outbreak response.

That is not true… my piece in ⁦@statnews⁩ https://t.co/LGluakA6ag

[Tedros Adhanom Ghebreyesus @DrTedros]

Women account for 67% of the health and care workforce and yet they are still paid 24% less on average than men working in the sector: https://t.co/1xbcli6wQU

This needs to end. #EqualPayDay

[Eric Topol @EricTopol]

Once again, ☕️☕️☕️ and caffeine linked with reduced cardiometabolic diseases
https://t.co/RqWBdFHvf6
From @uk_biobank, >170,000 participants

[nature @Nature]

Artificial intelligence is helping to redraw the virus family tree https://t.co/3VUCWGGESp

[Nature Reviews Bioengineering @natrevbioeng]

Information on clinical trial progress of implanted brain-computer interfaces remains scarce. Join our webinar with Pepe Contreras-Vidal and Mariska Vansteensel discussing the state of clinical trials of implantable brain-computer interfaces
Register here: https://t.co/GLYmGesm8r

[Maria Van Kerkhove @mvankerkhove]

🆕Recordings and presentations now available from the #Mpox research and innovation organized by @WHO @rd_blueprint @CEPIvaccines @AfricaCDC @NIH

Thanks to all those who contributed to aligning research response with the outbreak goals
@DrTedros
https://t.co/7YOijJLiq3